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This study investigated the presence of Entamoeba histolytica, Entamoeba dispar, and Entamoeba moshkovskii
in stool samples from a patient population in Sydney, Australia. Stool samples were tested by microscopy and
PCR. Five patients were found with E. histolytica infections, while E. dispar and E. moshkovskii were observed
in 63 (70.8%) and 55 (61.8%) patients, respectively, by PCR. This is the first study in Australia using molecular
techniques to determine the presence of E. histolytica, E. dispar, and E. moshkovskii.
The genus Entamoeba comprises six species (Entamoeba histo-
lytica, Entamoeba dispar, Entamoeba moshkovskii, Entamoeba
poleki, Entamoeba coli, and Entamoeba hartmanni) that live in
the human intestinal lumen. E. histolytica, E. dispar, and E.
moshkovskii are morphologically identical but are different bio-
chemically and genetically (1, 2, 3, 5, 6). Although E. histolytica
is recognized as a pathogen, the ability of the other two species
to cause disease is unclear. E. moshkovskii, for example, is
considered primarily a free-living ubiquitous amoeba found in
anoxic sediments (2), and E. dispar is considered primarily a
commensal of the human gut (3, 5).
Early studies of amebiasis in Australia have reported that
the incidence of Entamoeba species varies from 1 to 4% in
urban and rural communities, respectively (14). In another
study, Law et al. (8) reported a 37% prevalence of Entamoeba
in men who have sex with men. However, these studies did not
differentiate E. histolytica from E. dispar or E. moshkovskii.
The prevalence of E. histolytica, E. dispar, and E. moshkovskii
(hereafter called the E complex) in the Australian population
therefore remains unknown. The present study investigated
the presence of the E complex in clinical samples by micros-
copy and PCR directly in stool samples collected from patients
presenting with gastrointestinal symptoms.
All of the stool specimens (from a diverse patient popula-
tion) submitted to the Department of Microbiology at St. Vin-
cent’s Hospital, Sydney, Australia, during January 2003 to June
2006 for investigation of diarrhea were included in this study.
Specimens from outpatients were collected by the patient and
submitted to the laboratory as fresh specimens along with a
portion mixed with sodium acetate-acetic acid-formalin (SAF).
Specimens from inpatients or received without a portion fixed
in SAF were immediately preserved in SAF upon arrival at the
laboratory. The SAF-fixed specimens underwent permanent
staining with a modified iron-hematoxylin stain according to
the manufacturer’s recommendations (Fronine, Australia). Pa-
tients diagnosed with members of the E complex by micros-
copy of stained smears underwent further investigations.
DNA was extracted from fecal specimens (without fixatives)
from patients either fresh or after storage at 20°C (immedi-
ately frozen upon arrival at the laboratory). Briefly, the stool
sample (200 mg) was washed twice with 1 ml of sterile phos-
phate-buffered saline (pH 7.2), centrifuged for 5 min at 14,000
g, and DNA extracted according to the manufacturers in-
structions with the QIAGEN kit (QIAGEN, Hilden, Ger-
many).
Aspirated pus from a liver abscess was obtained from one
patient. The DNA was extracted from the liver abscess with the
QIAamp DNA tissue extraction kit.
PCR targeting of the 18S rRNA genes of E. histolytica and E.
dispar was carried out by following the protocol previously
described (15). For E. moshkovskii, a nested PCR was carried
out with primers targeting the E. moshkovskii-specific 18S
rRNA gene as previously described (1).
To exclude any inhibitory effect due to the presence of fecal
material inhibition, control experiments were carried out and
the DNA from the fecal specimens was spiked with an equal
volume of genomic DNA (2 l) from E. histolytica strain HTH-
56:MUTM, E. dispar strain SAW 760, or the 18S rRNA gene
cloned into plasmid pGEM-T. As a control for E. moshkovskii,
genomic DNA of the Laredo strain was used in separate ex-
periments.
A determination of the sensitivity of the PCR assay was
performed with genomic DNAs from control samples of E.
histolytica, E. dispar, and E. moshkovskii. Tenfold dilutions of
the DNA were added to the stool samples negative for para-
sitic cysts and ova by microscopy and negative by PCR with E.
histolytica-, E. dispar-, and E. moshkovskii-specific primers.
DNA was extracted from spiked fecal samples by using the
QIAamp DNA stool mini kit.
The PCR assay was also tested for specificity against a panel
of DNAs extracted from 26 fecal samples, each containing one
or a mixture of the following parasites: Blastocystis hominis,
Escherichia coli, E. hartmanni, Giardia intestinalis, Endolimax
nana, Iodamoeba butschlii, Cryptosporidium sp., Cyclospora sp.,
Chilomastix mesnili, and Enteromonas hominis.
For DNA sequencing, the PCR products were purified with
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the QIAquick PCR gel extraction kit (QIAGEN) in accor-
dance with the manufacturer’s instructions. The PCR products
were then sequenced in both directions with an ABI Prism
3700. The 18S rRNA gene sequences obtained were from
randomly selected PCR products derived from clinical speci-
mens positive for each Entamoeba species. The sequences were
compared to those available in the GenBank database with the
BLASTN program run on the National Center for Biotechnol-
ogy Information Server (http://www.ncbi.nlm.nih.gov/BLAST).
A total of 5,921 samples were tested over the period between
January 2003 and June 2006, and 177 (2.9%) samples were
microscopically positive for cysts or trophozoites of the E com-
plex, either singly or in combination with other human proto-
zoan parasites. Of the 177 microscopy-positive samples, only
110 were further studied as the rest of the samples were dis-
carded because they could not be preserved. The E complex
was found alone in 23 (21%) specimens, whereas the other 87
(79%) specimens contained the E complex with two or more
different parasite species (data not shown). B. hominis (60.9%)
was found to be the most common protozoan parasite, fol-
lowed by E. nana (42.7%), I. butschlii (15.4%), E. hartmanni
(11.8%), E. coli (11.8%), E. hominis (5.4%), G. intestinalis
(2.7%), and C. mesnili (1.8%).
Of the 110 patients who provided specimens, 107 (97.3%)
were male whereas only 3 (2.7%) were female. The majority of
the patients (70/110 or 63.6%) were 31 to 50 years old.
Results of inhibition controls for all PCRs carried out to
exclude the possibility that a negative PCR result was due to
failure of amplification showed no inhibition for any of the
samples.
The results of the PCR assays showed that they were able to
detect as little as 10 pg of DNA of E. histolytica, 1 pg of DNA
of E. dispar, and 0.506 fg of DNA of E. moshkovskii. All
samples were tested twice. No cross amplification was observed
when all of the sets of primer used in this study were tested
against infected stool DNA containing different protozoal
pathogens.
Microscopy-positive fecal samples containing the E complex
(n  110) were subject to PCR for confirmation of the diag-
nosis of E complex. PCR products were detected in 89 (81%)
samples, whereas 21 (19%) samples were found to be negative
by PCR assay. Of the 89 PCR-positive samples, 3 (3.4%) were
shown to contain only E. histolytica, 30 (33.7%) contained E.
dispar, and 22 (24.7%) contained only E. moshkovskii. Mixed
infection with E. dispar and E. moshkovskii was found in 32
(36%) specimens. One sample contained both E. histolytica
and E. dispar, while another sample contained both E. histo-
lytica and E. moshkovskii. The clinical data from E. histolytica-
positive patients are shown in Table 1. PCR of the DNA
extracted from the liver abscess pus was positive for E. histo-
lytica.
Representative PCR products were sequenced in both di-
rections from all of the 5 specimens of E. histolytica, 15 spec-
imens of E. dispar, and 15 specimens of E. moshkovskii. The
sequences of all the 15 E. dispar amplicons showed 98.5% to
100% similarity to the E. dispar sequences in GenBank (e.g.,
accession no. Z49256), whereas all of the five E. histolytica
sequences showed high similarity (99.7% to 100%) to the E.
histolytica sequences in GenBank (e.g., accession no. X56991).
All of the 15 E. moshkovskii amplicons showed 100% similarity
to the E. moshkovskii sequences in GenBank (e.g., accession
no. AF149906).
Of the 21 PCR-negative samples, 14 contained only tropho-
zoites, 1 sample was positive for cysts only, and 6 contained
trophozoites and cysts of the E complex. Every PCR-negative
sample was retested by PCR, and each was again found to be
PCR negative.
E. histolytica is the agent of human intestinal and extraint-
estinal amebiasis, a parasitic organism responsible for signifi-
cant morbidity and mortality, mainly in developing countries
and several communities of developed nations (10, 12). Accu-
rate differentiation of E. histolytica from E. dispar and E. mosh-
kovskii is crucial to the clinical management of patients. Cur-
rent data indicate that E. dispar is perhaps 10 times more
common than E. histolytica worldwide (12, 16), but the local
prevalence may vary significantly, thereby necessitating the
assessment of prevalence in different geographical regions. To
date, several microscopy-based epidemiological surveys to
study the prevalence of E. histolytica and E. dispar have been
performed in different parts of Australia, but they were carried
out without using molecular methods to accurately identify the
presence of individual species. Hence, none of these studies
have determined the true presence of E. histolytica, E. dispar,
or E. moshkovskii (8, 14).
In this study, the overall prevalence of the E complex was
found to be 2.9% by microscopy and permanent staining. By
TABLE 1. Clinical details of patients positive for E. histolytica by PCR
Patient age (yr)
and sex Microscopy result
TechLab ELISAa
result
PCR (E. histolytica)
result Clinical history Amebic serology
Overseas travel,
risk factor
36, male E complex, B. hominis Negative Positive Amebic dysentery Equivocal Thailand
35, male E complex, E. hartmanni,
B. hominis
Negative Positive Gastroenteritis (2 wk) Not done None, MSMd
31, male E complex, E. coli,
I. butschlii, B. hominis
Negative Positiveb Diarrhea, abdominal pain
(1–2 wk)
Not done None, MSM
53, male E complex Negative Positivec Gastroenteritis (1 wk) Not done None, MSM
57, male E complex, I. butschlii,
E. coli, E. hartmanni
Negative Positive Amebic dysentery, extraintestinal
disease, liver abscesse
Positive Thailand
a ELISA, enzyme-linked immunosorbent assay.
b Positive for E. dispar and E. histolytica by PCR.
c Positive for E. moshkovskii and E. histolytica by PCR.
d MSM, men who have sex with men.
e Positive for E. histolytica by PCR and by TechLab ELISA.
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molecular techniques, E. dispar and E. moshkovskii were found
to be the most prevalent Entamoeba species. A recent study in
Bangladesh has highlighted the prevalence of E. moshkovskii
(21%), suggesting that this infection is common among chil-
dren aged 2 to 5 years (1). A study in India linked E. mosh-
kovskii infection with dysentery (11). In our study, all of the
patients with E. moshkovskii infection were symptomatic.
Therefore, further investigations are needed of control and
other patient groups to determine the true pathogenic poten-
tial of E. moshkovskii.
Most (97.3%) of the patients with E complex were males and
predominantly men who have sex with men. These results are
in accordance with studies from other countries, which docu-
ment a higher prevalence of E. dispar in men who have sex with
men (4, 10). Of concern is the detection of E. histolytica in men
who have sex with men, highlighting the need for continued
monitoring of this particular population.
In this study, the PCR assay showed a sensitivity of 81%
compared to microscopy, which is much higher than the sen-
sitivity of 71.7% reported by Roy et al. (13), who used unfixed,
frozen stool samples. However, higher sensitivity levels, rang-
ing from 94 to 100%, obtained with microscopy-positive spec-
imens have been reported for unpreserved frozen stool speci-
mens (9, 15). In 21 (19%) samples positive for E complex by
microscopy, we were not able to PCR amplify DNA from any
member of the E complex with the primers used and no inhi-
bition of the PCR was observed in control experiments. These
results can potentially be explained by the presence of other
Entamoeba species, which were detected by microscopy but not
by PCR, or the presence of a low number of parasites in the
sample, which fell below the detection limit of PCR. Another
reason for this could be the fact that a majority of these sam-
ples (14/21) contained only trophozoites that could have de-
generated with time. Similar to the findings of Kebede et al.
(7), our PCR results show better concordance with the micro-
scopic finding of E complex cysts than with the microscopic
detection of E complex trophozoites. It therefore appears that
the presence of cysts in the fecal samples, in contrast to tro-
phozoites, can increase the chances of the PCR assay success-
fully detecting DNA from these three species.
This is the first study in Australia using molecular techniques
to determine the true incidence of E complex and highlights
the importance of molecular methods to differentiate among
the three species. The discovery of E. histolytica within the
homosexual community is of great public health concern. This
study reports for the first time the identification of E. mosh-
kovskii and E. dispar in clinical samples from Australia. Further
studies are needed to determine the true prevalence and
pathogenic potential of these two species.
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